» Articles » PMID: 17008870

Clinicopathological Significance of Homeoprotein Six1 in Hepatocellular Carcinoma

Overview
Journal Br J Cancer
Specialty Oncology
Date 2006 Sep 30
PMID 17008870
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Tumour recurrence and metastases of hepatocellular carcinoma (HCC) after hepatectomy are the major obstacles of long-term survival. The present study investigated the clinicopathological significance of a possible metastasis regulator Six1 in HCC patients who were undergone hepatectomy. Seventy-two pairs of RNA and 103 pairs of protein from tumour and adjacent nontumour liver tissues of HCC patients were examined. About 85 and 60% of HCC tumour tissues were found to overexpress Six1 mRNA and protein, respectively, compared with nontumour liver tissues. No Six1 protein was detected in HCC nontumour liver tissues and normal liver tissues. Increased Six1 protein expression in HCC patients was significantly correlated with pathologic tumour-node-metastasis (pTNM) stage (P=0.002), venous infiltration (P=0.004) and poor overall survival (P=0.0423). We concluded that Six1 is frequently overexpressed in HCC patients and elevated Six1 protein in HCC patients may be an indication of advanced stage and poor overall survival after hepatectomy.

Citing Articles

Sine oculis homeobox homolog family function in gastrointestinal cancer: Progression and comprehensive analysis.

Lan Y, Wu Z, Chen W, Yu X, Wu H, Liu J World J Clin Oncol. 2025; 16(1):97163.

PMID: 39867730 PMC: 11528897. DOI: 10.5306/wjco.v16.i1.97163.


Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma.

Zhou X, Hang S, Wang Q, Xu L, Wang P Biomolecules. 2024; 14(8).

PMID: 39199296 PMC: 11353135. DOI: 10.3390/biom14080908.


Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide.

Goleij P, Pourali G, Raisi A, Ravaei F, Golestan S, Abed A Mol Neurobiol. 2024; 62(2):1726-1755.

PMID: 39023794 DOI: 10.1007/s12035-024-04316-z.


Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.

Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J Acta Pharm Sin B. 2024; 14(3):953-1008.

PMID: 38487001 PMC: 10935242. DOI: 10.1016/j.apsb.2023.12.003.


In Vitro Phosphatase Assays for the Eya2 Tyrosine Phosphatase.

Alderman C, Krueger A, Rossi J, Ford H, Zhao R Methods Mol Biol. 2023; 2743:285-300.

PMID: 38147222 PMC: 11044973. DOI: 10.1007/978-1-0716-3569-8_18.


References
1.
Llovet J, Schwartz M, Mazzaferro V . Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25(2):181-200. DOI: 10.1055/s-2005-871198. View

2.
Reichenberger K, Coletta R, Schulte A, Varella-Garcia M, Ford H . Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res. 2005; 65(7):2668-75. DOI: 10.1158/0008-5472.CAN-04-4286. View

3.
Schafer D, Sorrell M . Hepatocellular carcinoma. Lancet. 1999; 353(9160):1253-7. DOI: 10.1016/S0140-6736(98)09148-X. View

4.
El-Serag H, Mason A . Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340(10):745-50. DOI: 10.1056/NEJM199903113401001. View

5.
Li Y, Tang Z, Ye S, Liu Y, Xue Q, Chen J . Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol. 2002; 7(5):630-6. PMC: 4695564. DOI: 10.3748/wjg.v7.i5.630. View